Bruce Booth - Jan 11, 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Director
Signature
/s/ Ommer Chohan, Attorney-in-Fact
Stock symbol
VIGL
Transactions as of
Jan 11, 2022
Transactions value $
$7,490,000
Form type
4
Date filed
1/11/2022, 08:11 PM
Previous filing
Jan 6, 2022
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIGL Common Stock Conversion of derivative security +2.83M +196.31% 4.27M Jan 11, 2022 By Atlas Venture Fund XII, L.P. F1, F2
transaction VIGL Common Stock Conversion of derivative security +1.03M 1.03M Jan 11, 2022 By Atlas Venture Opportunity Fund I, L.P. F1, F3
transaction VIGL Common Stock Purchase $7.49M +535K +12.52% $14.00 4.81M Jan 11, 2022 By Atlas Venture Fund XII, L.P. F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Series A Preferred Stock Conversion of derivative security $0 -7.85M -100% $0.00* 0 Jan 11, 2022 Common Stock 2.83M By Atlas Venture Fund XII, L.P. F1, F2
transaction VIGL Series B Preferred Stock Conversion of derivative security $0 -2.85M -100% $0.00* 0 Jan 11, 2022 Common Stock 1.03M By Atlas Venture Opportunity Fund I, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
F2 These shares are held directly by Atlas Venture Fund XII, L.P. ("Atlas Venture Fund XII"). The general partner of Atlas Venture Fund XII is Atlas Venture Associates XII, L.P. ("AVA XII LP"). Atlas Venture Associates XII, LLC ("AVA XII LLC") is the general partner of AVA XII LP. The Reporting Person is a member of AVA XII LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund XII, except to the extent of his pecuniary interest therein, if any.
F3 The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any.
F4 On January 11, 2022, Atlas Venture Fund XII purchased 535,000 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.